Medicines New Zealand Unveils 2022 Transfer of ...

By HEOR Staff Writer

August 30, 2023

Medicines New Zealand is delighted to announce the launch of the 2022 Transfer of Value reports. These reports, representing the organisation's second annual publication, offer a transparent snapshot of the financia...
Medicare Drug Price Negotiations Expected to Generate $1.8 Billion in Savings...
Further Research Required for Aortic Valve Reconstruction Procedure, Says NICE
Transforming Paediatric Care: Virtual Care Modalities Prove Effective and Pro...
The Potential Expansion of Ireland’s Seasonal Influenza Vaccination Pro...
Major Updates from the Pharmaceutical Benefits Advisory Committee
Thermidas: A Breakthrough in Non-Invasive Skin Temperature Measurement
Empowering Ethiopia: Horizon Europe Grants €4M to Tackle Non-Communicable Dis...
Empowering Pharmacists: South African Court Ruling Greenlights Pharmacist-Pre...
Unlocking Health Equity through Digital Health Technologies
Advancing Antibiotic Use and Preventing Hearing Loss in Babies: Evidence-gene...
Unlocking the Value of Biosimilars: Challenges and Solutions
WHO Approves Essential Medicines for Multiple Sclerosis while Obesity Drugs a...